Exploiting the potential of photon-counting CT in abdominal imaging

FR Schwartz, E Samei, D Marin - Investigative Radiology, 2023 - journals.lww.com
Photon-counting computed tomography (PCCT) imaging uses a new detector technology to
provide added information beyond what can already be obtained with current CT and MR …

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

H Chen, Y Pang, J Wu, L Zhao, B Hao, J Wu… - European journal of …, 2020 - Springer
Purpose We evaluated the potential usefulness of [68 Ga] Ga-DOTA-FAPI-04 positron
emission tomography/computed tomography (PET/CT) for the diagnosis of primary and …

[HTML][HTML] Radiomics in colorectal cancer patients

R Inchingolo, C Maino, R Cannella… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The main therapeutic options for colorectal cancer are surgical resection and adjuvant
chemotherapy in non-metastatic disease. However, the evaluation of the overall adjuvant …

The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG

L Lan, H Liu, Y Wang, J Deng, D Peng, Y Feng… - European journal of …, 2022 - Springer
Purpose This study aimed to compare the detection performance of [68 Ga] Ga-DOTA-FAPI-
04 and [18F] FDG PET/CT in the patients with various oncological and non-oncological …

68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT

H Kömek, C Can, Y Güzel, Z Oruç, C Gündoğan… - Annals of nuclear …, 2021 - Springer
Aim We aimed to compare the roles of 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in the
evaluation of primary tumor and metastases in primary and recurrent breast cancer …

Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and …

L Zhao, Y Pang, H Zheng, C Han, J Gu, L Sun… - European journal of …, 2021 - Springer
Purpose This study aimed to explore the clinical utility of [68 Ga] Ga-labeled fibroblast
activation protein inhibitor ([68 Ga] Ga-FAPI) positron emission tomography/computed …

Prospective Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Tumor Staging in Biliary Tract Cancers

L Lan, S Zhang, T Xu, H Liu, W Wang, Y Feng, L Wang… - Radiology, 2022 - pubs.rsna.org
Background Gallium 68–labeled fibroblast-activation protein inhibitor (68Ga-FAPI), an
imaging agent for detecting tumors, represents a promising alternative to fluorine 18 …

Usefulness of [68Ga]FAPI-04 and [18F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study

C Li, Y Tian, J Chen, Y Jiang, Z Xue, D Xing, B Wen… - European …, 2023 - Springer
Objective To assess and compare the diagnostic performance of gallium-68-labelled
fibroblast activation protein inhibitor ([68Ga] FAPI-04) and fluorine-18 fluorodeoxyglucose …

The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience

X Jia, X Li, B Jia, Y Yang, Y Wang, Y Liu, T Ji… - European Journal of …, 2023 - Springer
Abstract Background Recently, PET/CT imaging with radiolabelled FAP inhibitors (FAPIs)
has been widely evaluated in diverse diseases. However, rare report has been published …

[HTML][HTML] Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases

M Li, X Li, Y Guo, Z Miao, X Liu, S Guo… - Quantitative imaging in …, 2020 - ncbi.nlm.nih.gov
Background This article aims to develop and assess the radiomics paradigm for predicting
colorectal cancer liver metastasis (CRLM) from the primary tumor. Methods This …